181 related articles for article (PubMed ID: 2578092)
21. Biochemical pharmacology of acivicin in rat hepatoma cells.
Lui MS; Kizaki H; Weber G
Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
[TBL] [Abstract][Full Text] [Related]
22. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
Ramu A; Cohen L; Glaubiger D
Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
[TBL] [Abstract][Full Text] [Related]
23. Effect of acivicin on glutamine transport by rat renal brush border membrane vesicles.
Sastrasinh S; Sastrasinh M
J Lab Clin Med; 1986 Oct; 108(4):301-8. PubMed ID: 2876045
[TBL] [Abstract][Full Text] [Related]
24. Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
Neil GL; Berger AE; McPartland RP; Grindey GB; Bloch A
Cancer Res; 1979 Mar; 39(3):852-6. PubMed ID: 427775
[No Abstract] [Full Text] [Related]
25. Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil.
Ardalan B; Cooney DA; Jayaram HN; Carrico CK; Glazer RI; Macdonald J; Schein PS
Cancer Res; 1980 May; 40(5):1431-7. PubMed ID: 6245793
[TBL] [Abstract][Full Text] [Related]
26. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
Denton JE; Lui MS; Aoki T; Sebolt J; Weber G
Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346
[TBL] [Abstract][Full Text] [Related]
27. The effects of a leukaemia-controlling dose of acivicin on murine splenic lymphocytes in vitro and in vivo.
Griffiths M; Keast D
Immunol Cell Biol; 1991 Dec; 69 ( Pt 6)():395-402. PubMed ID: 1813388
[TBL] [Abstract][Full Text] [Related]
28. Mechanism for acivicin inactivation of triad glutamine amidotransferases.
Chittur SV; Klem TJ; Shafer CM; Davisson VJ
Biochemistry; 2001 Jan; 40(4):876-87. PubMed ID: 11170408
[TBL] [Abstract][Full Text] [Related]
29. Therapy for mouse tumors and human tumor xenografts with the antitumor antibiotic AT-125.
Houchens DP; Ovejera AA; Sheridan MA; Johnson RK; Bogden AE; Neil GL
Cancer Treat Rep; 1979 Mar; 63(3):473-6. PubMed ID: 427827
[TBL] [Abstract][Full Text] [Related]
30. In vivo inactivation of formylglycinamidine ribonucleotide synthetase in rat hepatoma.
Elliott WL; Weber G
Biochem Pharmacol; 1985 Jan; 34(2):243-8. PubMed ID: 3966925
[TBL] [Abstract][Full Text] [Related]
31. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
Ganapathi R; Reiter W; Krishan A
J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
[TBL] [Abstract][Full Text] [Related]
32. Effects of acivicin and dipyridamole on hepatoma 3924A cells.
Zhen YS; Lui MS; Weber G
Cancer Res; 1983 Apr; 43(4):1616-9. PubMed ID: 6831407
[TBL] [Abstract][Full Text] [Related]
33. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
Inaba M; Nagashima K
Jpn J Cancer Res; 1986 Feb; 77(2):197-204. PubMed ID: 3082832
[TBL] [Abstract][Full Text] [Related]
34. Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.
Ahluwalia GS; Cohen MB; Kang GJ; Arnold ST; McMahon JB; Dalal M; Wilson YA; Cooney DA; Balzarini J; Johns DG
Cancer Res; 1986 Sep; 46(9):4479-85. PubMed ID: 2425954
[TBL] [Abstract][Full Text] [Related]
35. [Characteristics of anthracycline-resistant strains of P388 leukemia].
Goncharova SA; Demidova NS; Shiriaeva OA; Shevtsova VN; Konovalova NP
Eksp Onkol; 1987; 9(4):42-7. PubMed ID: 3678124
[TBL] [Abstract][Full Text] [Related]
36. [Phosphorus-containing metabolites in the cells of anthracycline-resistant strains of leukemia P388].
Shiriaeva OA; Semenova NA; Sibel'dina LA; Goncharova SA; Konovalova NP
Eksp Onkol; 1989; 11(4):70-3. PubMed ID: 2759015
[TBL] [Abstract][Full Text] [Related]
37. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
Ramu A; Fuks Z; Gatt S; Glaubiger D
Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
[TBL] [Abstract][Full Text] [Related]
38. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
Kensler TW; Jayaram HN; Cooney DA
Adv Enzyme Regul; 1982; 20():57-73. PubMed ID: 7113804
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
[TBL] [Abstract][Full Text] [Related]
40. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide.
Ido M; Sato K; Sakurai M; Inagaki M; Saitoh M; Watanabe M; Hidaka H
Cancer Res; 1987 Jul; 47(13):3460-3. PubMed ID: 3581082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
